詳細検索

詳細検索

お問い合わせ

Artificial Organs Medical Bionics Market Insights, Competitive Landscape, and Market Forecast - 2033

Artificial Organs Medical Bionics Market Insights, Competitive Landscape, and Market Forecast - 2033


The Artificial Organs and Medical Bionics Market is rapidly evolving as healthcare systems worldwide adopt advanced technologies to address the growing burden of organ failure and physical disabili... もっと見る

 

 

出版社
Fairfield Market Research
フェアフィールドマーケットリサーチ
出版年月
2026年5月7日
電子版価格
US$4,995
シングルユーザライセンス
ライセンス・価格情報/注文方法はこちら
納期
通常5営業日以内
ページ数
192
言語
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The Artificial Organs and Medical Bionics Market is rapidly evolving as healthcare systems worldwide adopt advanced technologies to address the growing burden of organ failure and physical disabilities. Artificial organs and bionic devices are designed to replicate or enhance the functions of biological systems, offering patients improved survival rates and quality of life. These solutions are particularly crucial in scenarios where organ transplantation is limited by donor shortages. With continuous progress in biomedical engineering and material science, the market is gaining strong momentum across both developed and emerging economies.

Market Insights

The global Artificial Organs and Medical Bionics Market is expected to reach US$ 37.1 billion in 2026 and grow to US$ 63.9 billion by 2033, registering a CAGR of 8.10% over the forecast period. This growth reflects increasing demand for advanced medical solutions capable of restoring critical body functions. Innovations in implantable devices, coupled with advancements in wearable bionics, are significantly expanding treatment possibilities. The market is also benefiting from increasing healthcare investments and rising awareness among patients and healthcare providers regarding technologically advanced therapeutic options.

Market Drivers

A major factor driving market expansion is the rising incidence of chronic diseases such as cardiovascular disorders, kidney failure, and neurological conditions. These diseases often require long-term intervention, making artificial organs and bionic devices indispensable. Additionally, the persistent gap between organ demand and donor availability is accelerating the adoption of artificial alternatives, particularly for vital organs like the heart and kidneys.

Technological advancements in biomaterials have also played a key role in improving device efficiency and patient compatibility. The use of advanced metals, polymers, and ceramics has enhanced the durability and performance of these devices. Moreover, the growing elderly population, which is more prone to organ degeneration and mobility issues, continues to support market growth. Increasing focus on rehabilitation and assistive technologies further contributes to the rising demand.

Business Opportunity

The Artificial Organs and Medical Bionics Market presents substantial growth opportunities, especially in developing regions where healthcare infrastructure is expanding. Companies are actively investing in research and development to create next-generation devices with improved accuracy, reliability, and patient comfort. The integration of digital health technologies, including sensors and real-time monitoring systems, is opening new avenues for personalized treatment and remote patient management.

Another key opportunity lies in making these technologies more affordable and accessible. Manufacturers are exploring cost-effective production techniques to expand their reach in price-sensitive markets. Strategic collaborations between medical device companies, research institutions, and healthcare providers are expected to drive innovation and accelerate product commercialization. Favorable regulatory frameworks supporting advanced medical technologies are also encouraging new market entrants.

Region Analysis

North America remains the leading region in the Artificial Organs and Medical Bionics Market, supported by a well-established healthcare system, strong research capabilities, and early adoption of advanced medical technologies. The presence of major companies such as Medtronic plc. and Zimmer Biomet Ltd. further strengthens the region’s dominance. Additionally, supportive reimbursement policies contribute to higher adoption rates.

Europe holds a significant share of the market, driven by increasing healthcare expenditure and strong government support for innovation in medical technologies. Countries such as Germany, the United Kingdom, and France are key contributors to regional growth.

The Asia Pacific region is projected to experience the fastest growth during the forecast period. Factors such as expanding healthcare infrastructure, rising awareness, and a large patient population are driving demand in countries like China and India. Increased investments in medical technology and improving access to healthcare services are further supporting market expansion.

Latin America and the Middle East and Africa are gradually emerging as potential markets, with improving healthcare facilities and growing investments in advanced treatment solutions.

Key Players

The Artificial Organs and Medical Bionics Market is highly competitive, with several prominent players focusing on innovation, product development, and strategic partnerships to strengthen their market position. Key companies include:

• Zimmer Biomet Ltd.

• Cochlear Ltd.

• Second Sight Medical Products, Inc.

• Ossur hf

• Rewalk Robotics Ltd.

• Orthofix International N.V.

• Ekso Bionics Holdings Inc.

• Medtronic plc.

These players are actively engaged in expanding their global footprint through mergers, acquisitions, and continuous innovation in product offerings.

Segmentation

By Organ Type

• Kidney

• Heart

• Bones

• Ear

• Eye

• Brain

• Other

By Biomaterial

• Metals

• Polymers

• Ceramics

• Other

By Technology

• Implantable

• Wearable

By Geographic Coverage

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

ページTOPに戻る


Table of Contents

1. Executive Summary
1.1. Global Artificial Organs Medical Bionics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Artificial Organs Medical Bionics Market Outlook, 2020 - 2033
3.1. Global Artificial Organs Medical Bionics Market Outlook, by Organ Type, Value (US$ Bn), 2020-2033
3.1.1. Kidney
3.1.2. Heart
3.1.3. Bones
3.1.4. Ear
3.1.5. Eye
3.1.6. Brain
3.1.7. Other
3.2. Global Artificial Organs Medical Bionics Market Outlook, by Biomaterial, Value (US$ Bn), 2020-2033
3.2.1. Metals
3.2.2. Polymers
3.2.3. Ceramics
3.2.4. Other
3.3. Global Artificial Organs Medical Bionics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
3.3.1. Implantable
3.3.2. Wearable
3.4. Global Artificial Organs Medical Bionics Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Artificial Organs Medical Bionics Market Outlook, 2020 - 2033
4.1. North America Artificial Organs Medical Bionics Market Outlook, by Organ Type, Value (US$ Bn), 2020-2033
4.1.1. Kidney
4.1.2. Heart
4.1.3. Bones
4.1.4. Ear
4.1.5. Eye
4.1.6. Brain
4.1.7. Other
4.2. North America Artificial Organs Medical Bionics Market Outlook, by Biomaterial, Value (US$ Bn), 2020-2033
4.2.1. Metals
4.2.2. Polymers
4.2.3. Ceramics
4.2.4. Other
4.3. North America Artificial Organs Medical Bionics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
4.3.1. Implantable
4.3.2. Wearable
4.4. North America Artificial Organs Medical Bionics Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
4.4.2. U.S. Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
4.4.3. U.S. Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
4.4.4. Canada Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
4.4.5. Canada Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
4.4.6. Canada Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Artificial Organs Medical Bionics Market Outlook, 2020 - 2033
5.1. Europe Artificial Organs Medical Bionics Market Outlook, by Organ Type, Value (US$ Bn), 2020-2033
5.1.1. Kidney
5.1.2. Heart
5.1.3. Bones
5.1.4. Ear
5.1.5. Eye
5.1.6. Brain
5.1.7. Other
5.2. Europe Artificial Organs Medical Bionics Market Outlook, by Biomaterial, Value (US$ Bn), 2020-2033
5.2.1. Metals
5.2.2. Polymers
5.2.3. Ceramics
5.2.4. Other
5.3. Europe Artificial Organs Medical Bionics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
5.3.1. Implantable
5.3.2. Wearable
5.4. Europe Artificial Organs Medical Bionics Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
5.4.2. Germany Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
5.4.3. Germany Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
5.4.4. Italy Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
5.4.5. Italy Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
5.4.6. Italy Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
5.4.7. France Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
5.4.8. France Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
5.4.9. France Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
5.4.10. U.K. Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
5.4.11. U.K. Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
5.4.12. U.K. Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
5.4.13. Spain Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
5.4.14. Spain Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
5.4.15. Spain Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
5.4.16. Russia Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
5.4.17. Russia Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
5.4.18. Russia Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
5.4.19. Rest of Europe Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
5.4.20. Rest of Europe Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
5.4.21. Rest of Europe Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Artificial Organs Medical Bionics Market Outlook, 2020 - 2033
6.1. Asia Pacific Artificial Organs Medical Bionics Market Outlook, by Organ Type, Value (US$ Bn), 2020-2033
6.1.1. Kidney
6.1.2. Heart
6.1.3. Bones
6.1.4. Ear
6.1.5. Eye
6.1.6. Brain
6.1.7. Other
6.2. Asia Pacific Artificial Organs Medical Bionics Market Outlook, by Biomaterial, Value (US$ Bn), 2020-2033
6.2.1. Metals
6.2.2. Polymers
6.2.3. Ceramics
6.2.4. Other
6.3. Asia Pacific Artificial Organs Medical Bionics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
6.3.1. Implantable
6.3.2. Wearable
6.4. Asia Pacific Artificial Organs Medical Bionics Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
6.4.2. China Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
6.4.3. China Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
6.4.4. Japan Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
6.4.5. Japan Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
6.4.6. Japan Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
6.4.7. South Korea Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
6.4.8. South Korea Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
6.4.9. South Korea Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
6.4.10. India Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
6.4.11. India Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
6.4.12. India Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
6.4.13. Southeast Asia Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
6.4.14. Southeast Asia Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
6.4.15. Southeast Asia Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
6.4.16. Rest of SAO Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
6.4.17. Rest of SAO Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
6.4.18. Rest of SAO Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Artificial Organs Medical Bionics Market Outlook, 2020 - 2033
7.1. Latin America Artificial Organs Medical Bionics Market Outlook, by Organ Type, Value (US$ Bn), 2020-2033
7.1.1. Kidney
7.1.2. Heart
7.1.3. Bones
7.1.4. Ear
7.1.5. Eye
7.1.6. Brain
7.1.7. Other
7.2. Latin America Artificial Organs Medical Bionics Market Outlook, by Biomaterial, Value (US$ Bn), 2020-2033
7.2.1. Metals
7.2.2. Polymers
7.2.3. Ceramics
7.2.4. Other
7.3. Latin America Artificial Organs Medical Bionics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
7.3.1. Implantable
7.3.2. Wearable
7.4. Latin America Artificial Organs Medical Bionics Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
7.4.2. Brazil Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
7.4.3. Brazil Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
7.4.4. Mexico Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
7.4.5. Mexico Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
7.4.6. Mexico Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
7.4.7. Argentina Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
7.4.8. Argentina Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
7.4.9. Argentina Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
7.4.10. Rest of LATAM Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
7.4.11. Rest of LATAM Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
7.4.12. Rest of LATAM Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Artificial Organs Medical Bionics Market Outlook, 2020 - 2033
8.1. Middle East & Africa Artificial Organs Medical Bionics Market Outlook, by Organ Type, Value (US$ Bn), 2020-2033
8.1.1. Kidney
8.1.2. Heart
8.1.3. Bones
8.1.4. Ear
8.1.5. Eye
8.1.6. Brain
8.1.7. Other
8.2. Middle East & Africa Artificial Organs Medical Bionics Market Outlook, by Biomaterial, Value (US$ Bn), 2020-2033
8.2.1. Metals
8.2.2. Polymers
8.2.3. Ceramics
8.2.4. Other
8.3. Middle East & Africa Artificial Organs Medical Bionics Market Outlook, by Technology, Value (US$ Bn), 2020-2033
8.3.1. Implantable
8.3.2. Wearable
8.4. Middle East & Africa Artificial Organs Medical Bionics Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
8.4.2. GCC Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
8.4.3. GCC Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
8.4.4. South Africa Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
8.4.5. South Africa Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
8.4.6. South Africa Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
8.4.7. Egypt Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
8.4.8. Egypt Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
8.4.9. Egypt Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
8.4.10. Nigeria Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
8.4.11. Nigeria Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
8.4.12. Nigeria Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
8.4.13. Rest of Middle East Artificial Organs Medical Bionics Market Outlook, by Organ Type, 2020-2033
8.4.14. Rest of Middle East Artificial Organs Medical Bionics Market Outlook, by Biomaterial, 2020-2033
8.4.15. Rest of Middle East Artificial Organs Medical Bionics Market Outlook, by Technology, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Zimmer Biomet Ltd.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Cochlear Ltd.
9.4.3. Second Sight Medical Products, Inc.
9.4.4. Ossur hf
9.4.5. Rewalk Robotics Ltd.
9.4.6. Orthofix International N.V.
9.4.7. Ekso Bionics Holdings Inc.
9.4.8. Medtronic plc.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(artificial)の最新刊レポート


よくあるご質問


Fairfield Market Research社はどのような調査会社ですか?


Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/06/08 10:26

161.38 円

186.42 円

218.06 円

ページTOPに戻る